Search research articles
Contact Us
Filters
Showing results (401-410 of 415) with videos related to
Page
of 42
Sort By:
Journal of Medicinal Chemistry
|
June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis
Rama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Journal of Medicinal Chemistry
|
February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines
Rolf Wagner, Daniel P Larson, David W A Beno, et al.
Journal of Medicinal Chemistry
|
June 9, 2006
Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors
Zhonghua Pei, Xiaofeng Li, Kenton Longenecker, et al.
International Journal for Parasitology
|
September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis
Matthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Alimentary Pharmacology & Therapeutics
|
February 28, 2024
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis
Marcus M Mücke, María Hernández-Tejero, Wenyi Gu, et al.
American Journal of Physiology. Cell Physiology
|
June 5, 2023
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure
Robert Schierwagen, Wenyi Gu, Angela Brieger, et al.
International Journal for Parasitology
|
April 1, 2020
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned
Ryan Choi, Matthew A Hulverson, Wenlin Huang, et al.
Emerging Infectious Diseases
|
November 20, 2019
Canine Leishmaniasis Control in the Context of One Health
Filipe Dantas-Torres, Guadalupe Miró, Gad Baneth, et al.
Journal of Medicinal Chemistry
|
October 13, 2006
Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes
David J Madar, Hana Kopecka, Daisy Pireh, et al.
Diagnostics (Basel, Switzerland)
|
August 7, 2021
Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
Alex van Belkum, Carina Almeida, Benjamin Bardiaux, et al.
Page
of 42
Search research articles
Search
Showing results (401-410 of 415) with videos related to
Sort By:
Page
of 42
Journal of Medicinal Chemistry
|
June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis
Rama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Journal of Medicinal Chemistry
|
February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines
Rolf Wagner, Daniel P Larson, David W A Beno, et al.
Journal of Medicinal Chemistry
|
June 9, 2006
Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors
Zhonghua Pei, Xiaofeng Li, Kenton Longenecker, et al.
International Journal for Parasitology
|
September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis
Matthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Alimentary Pharmacology & Therapeutics
|
February 28, 2024
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis
Marcus M Mücke, María Hernández-Tejero, Wenyi Gu, et al.
American Journal of Physiology. Cell Physiology
|
June 5, 2023
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure
Robert Schierwagen, Wenyi Gu, Angela Brieger, et al.
International Journal for Parasitology
|
April 1, 2020
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned
Ryan Choi, Matthew A Hulverson, Wenlin Huang, et al.
Emerging Infectious Diseases
|
November 20, 2019
Canine Leishmaniasis Control in the Context of One Health
Filipe Dantas-Torres, Guadalupe Miró, Gad Baneth, et al.
Journal of Medicinal Chemistry
|
October 13, 2006
Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes
David J Madar, Hana Kopecka, Daisy Pireh, et al.
Diagnostics (Basel, Switzerland)
|
August 7, 2021
Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
Alex van Belkum, Carina Almeida, Benjamin Bardiaux, et al.
Page
of 42